The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44 - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Biochemical and Biophysical Research Communications Année : 2022

The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44

Résumé

CD44 mRNA contains nine consecutive cassette exons, v2 to v10. Upon alternative splicing, several isoforms are produced with different impacts on tumor biology. Here, we demonstrate the involvement of the RNA-binding proteins CELF1 and ELAVL1 in the control of CD44 splicing. We show by FRET-FLIM that these proteins directly interact in the nucleus. By combining RNAi-mediated depletion and exon array hybridization in HeLa cells, we observe that the exons v7 to v10 of CD44 are highly sensitive to CELF1 and ELAVL1 depletion. We confirm by RT-PCR that CELF1 and ELAVL1 together stimulate the inclusion of these exons in CD44 mRNA. Finally, we show in eight different tumor types that high expression of CELF1 and/or ELAVL1 is correlated with the inclusion of CD44 variable exons. These data point to functional interactions between CELF1 and ELAVL1 in the control of CD44 splicing in human cancers.
Fichier principal
Vignette du fichier
David et al - 2022 - The RNA-binding proteins CELF1 and ELAVL1.pdf (1.37 Mo) Télécharger le fichier
David_ScienceDirect_files_14Dec2022_14-19-26.010.zip (112.17 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03757363 , version 1 (14-12-2022)

Identifiants

Citer

Géraldine David, David Reboutier, Stéphane Deschamps, Agnès Méreau, William Taylor, et al.. The RNA-binding proteins CELF1 and ELAVL1 cooperatively control the alternative splicing of CD44. Biochemical and Biophysical Research Communications, 2022, 626, pp.79-84. ⟨10.1016/j.bbrc.2022.07.073⟩. ⟨hal-03757363⟩
105 Consultations
50 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More